Pharmaceuticals · Key players

Top Lipid-Lowering Drugs companies

The 6 key players our Lipid-Lowering Drugs report profiles, and other companies free public records show in this market.

Key players in Lipid-Lowering Drugs

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Lipid-Lowering Drugs market
#CompanyWebsiteOur reports
1 Pfizer Inc. pfizer.com (opens in a new tab) 2,310 reports
2 Amgen Inc. amgen.com (opens in a new tab) 693 reports
3 Novartis AG novartis.com (opens in a new tab) 1,551 reports
4 Merck & Co., Inc. merck.com (opens in a new tab) 1,320 reports
5 Esperion Therapeutics — 33 reports
6 AstraZeneca astrazeneca.com (opens in a new tab) 957 reports

Also active in Lipid-Lowering Drugs

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Lipid-Lowering Drugs, from free public records
CompanyWhere public records show them
Aurobindo Pharma
Alkem Laboratories Ltd
Qilu Pharmaceutical Co., Ltd.
Dr Reddy’s Laboratories
Zydus Lifesciences
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Chartwell RX
Daiichi Sankyo Company
Glenmark Pharmaceuticals
Accord Healthcare
Verve Therapeutics
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Lipid-Lowering Drugs

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Novartis AG 14 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Qilu Pharmaceutical Co., Ltd. 5 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Merck & Co., Inc. 5 active trials on ClinicalTrials.gov (opens in a new tab)
  4. AstraZeneca 4 active trials on ClinicalTrials.gov (opens in a new tab)
  5. CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Daiichi Sankyo Company 4 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Verve Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Jiangsu Hansoh Pharmaceutical Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Lipid-Lowering Drugs reports by place

All 33 places for Lipid-Lowering Drugs

Get the full Lipid-Lowering Drugs report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.